The Nation

Lawyers for plaintiffs in the Bendectin lawsuit against Merrell Dow Pharmaceuticals asked a federal judge for a new trial, citing what they said were 43 errors made by the pharmaceutical company's lawyers. More than 1,100 plaintiffs nationwide have charged that Bendectin, an anti-nausea drug used to treat pregnant women, caused birth defects in their children. On March 13, a U.S. District Court jury found in favor of Merrell Dow, the Cincinnati-based company that manufactured the drug until 1983.

Copyright © 2019, Los Angeles Times
EDITION: California | U.S. & World
60°